COMPANY

CellMax Life

HQ: Sunnyvale, CA (US office) source · cellmaxlife.com ↗ · West Coast

Keywords: oncology Colorectal Cancer Screening Breast Cancer Prostate Cancer Colo-rectal Cancer

Location: Sunnyvale, CA (US office) · source · Oct 15, 2026

Profile checked Oct 10, 2026

Timeline

Dec 15, 2020 Trial start —: Sample Collection Study for the CellMax Life Circulating Tumor Cell and Circulating Tumor DNA Platforms for the Early Detection of Colorectal Cancer and Adenomas source ↗
Mar 15, 2018 Trial start —: Clinical Application of an Automated Liquid Biopsy Platform for Early Detection of Colorectal Cancer source ↗
Jan 17, 2018 Trial start —: Assessing Circulating Tumor Cell as a Biomarker for Prostate Cancer Detection in Patients With Gray Zone PSA Level source ↗
Nov 16, 2017 Trial start —: Detecting Circulating Tumor Cells (CTCs) and Cell Free DNA (cfDNA) in Peripheral Blood of Breast Cancer (BC) Patients to Develop the Clinical Application for Early Detection and Diagnostics source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT05127096	Sample Collection Study for the CellMax Life Circulating Tumor Cell and Circulating Tumor DNA Platforms for the Early Detection of Colorectal Cancer and Adenomas	Not listed	Unknown status (ClinicalTrials.gov)	Dec 15, 2020	Sep 30, 2022 (estimated)
NCT03511859	Detecting Circulating Tumor Cells (CTCs) and Cell Free DNA (cfDNA) in Peripheral Blood of Breast Cancer (BC) Patients to Develop the Clinical Application for Early Detection and Diagnostics	Not listed	Unknown status (ClinicalTrials.gov)	Nov 16, 2017	Dec 31, 2018 (estimated)
NCT03488706	Assessing Circulating Tumor Cell as a Biomarker for Prostate Cancer Detection in Patients With Gray Zone PSA Level	Not listed	Unknown status (ClinicalTrials.gov)	Jan 17, 2018	Dec 12, 2018 (estimated)
NCT03476122	Clinical Application of an Automated Liquid Biopsy Platform for Early Detection of Colorectal Cancer	Not listed	Unknown status (ClinicalTrials.gov)	Mar 15, 2018	Jan 1, 2019 (estimated)